Oncogenic ras-specific cytotoxic compound and methods of use...

Details Oncogenic ras-specific cytotoxic compound and methods of use... Oncogenic ras-specific cytotoxic compound and methods of use...

A - Human Necessities

61

K

A61K 31/404 (2006.01) A61K 31/427 (2006.01) A61P 31/12 (2006.01) A61P 35/00 (2006.01) C12N 5/00 (2006.01)

Patent

CA 2631082

Embodiments of the present invention provide for methods and compositions comprising an Oncorasin, such as l-[(4-chlorophenyl)methyl]- lH-Indole-3- carboxaldehyde (oncrasin-1) and/or its analogs or derivatives.

Les modes de réalisation de la présente invention concernent des procédés et des compositions comprenant une oncorasine, telle que la l-[(4-chlorophényl)méthyl]- lH-Indole-3-carboxaldéhyde (oncrasin-1) et/ou ses analogues ou dérivés.

Affiliated with

Also associated with

Rating

Oncogenic ras-specific cytotoxic compound and methods of use... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oncogenic ras-specific cytotoxic compound and methods of use..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oncogenic ras-specific cytotoxic compound and methods of use... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1681601